Resveratrol in Type2 Diabetes and Obesity

Summary

The main objective of this study is to investigate the effect of resveratrol (plant derived food supplement) on inflammatory mediators and insulin resistance at the cellular and molecular level in obese non diabetic and type 2 diabetic subjects in vivo.

Timeline

Start

2008-12

Primary completion

2012-07-08

Completion

2012-07-08

Outcome

Outcome not reported

Stopped: “FDA clinical hold requiring IND submission, product not available in the market anymore”

Drugs

Indications